Overview

  • Product nameZ-VDVAD-FMK
  • Description
    Irreversible caspase-2 inhibitor
  • Biological descriptionIrreversible caspase-2 inhibitor. Inhibits apoptosis in multiple biological systems.

Properties

  • Molecular weight695.70
  • Chemical structureChemical Structure
  • Molecular formulaC32H46FN5O11
  • SequenceVDVAD (Modifications: N-terminal benzyloxycarbonyl; C-terminal FMK; Asp-2 = Asp(OMe); Asp-5 = Asp(OMe))
  • PubChem identifier25108684
  • Storage instructionsStore at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.
  • Solubility overviewSoluble in DMSO to 20 mM
  • Handling

    Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one week. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

    Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

  • SMILESCC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)C(CC(=O)OC)NC(=O)C(C(C)C)NC(=O)OCC1=CC=CC=C1
  • Source

    Synthetic

  • Research areas

    Applications

    Our Abpromise guarantee covers the use of ab142035 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    Application Abreviews Notes
    Functional Studies Use at an assay dependent concentration.

    Z-VDVAD-FMK images

    • ab13847 staining active caspase 3 in SKNSH cells treated with Z-VDVAD-FMK (ab142035), by ICC/IF. Decrease in active caspase 3 expression correlates with increased concentration of Z-VDVAD-FMK, as described in literature.
      The cells were incubated at 37°C for 1 hour in media containing different concentrations of ab142035 (Z-VDVAD-FMK) in DMSO. After this incupation 10 µM of camptothecin (ab120115) was added to all samples and the cells were incubated for further 24 hours. The samples were then fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab13847 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

    References for Z-VDVAD-FMK (ab142035)

    This product has been referenced in:
    • Chauvier D  et al. Upstream control of apoptosis by caspase-2 in serum-deprived primary neurons. Apoptosis 10:1243-59 (2005). Read more (PubMed: 16215683) »
    • Robertson JD  et al. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 277:29803-9 (2002). Read more (PubMed: 12065594) »
    • Meguro T  et al. Caspase inhibitors attenuate oxyhemoglobin-induced apoptosis in endothelial cells. Stroke 32:561-6 (2001). Read more (PubMed: 11157197) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab142035.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"